TI
WHWK

Trexquant Investment’s Whitehawk Therapeutics WHWK Stock Holding History

Trexquant Investment’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,847
Closed -$182K – 1804
2022
Q3 		$182K Buy
+12,847
New +$169K 0.01% 1211

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Trexquant Investment's WHWK Position: Q4 2022 in Review

Trexquant Investment sold out of Whitehawk Therapeutics (WHWK) in Q4 2022, closing a stake of 12,847 shares — an estimated $182K sold.

Trexquant Investment first reported a position in WHWK in Q3 2022 and held it in 1 quarter. The position peaked at $182K in Q3 2022. 76 funds tracked by Wall St. Rank hold WHWK as of Q4 2022.

  • Trexquant Investment reported no remaining Whitehawk Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Trexquant Investment sold 12,847 Whitehawk Therapeutics shares in Q4 2022, an estimated $182K.
  • Trexquant Investment first reported a position in Whitehawk Therapeutics in Q3 2022 and held it in 1 quarter.
  • Trexquant Investment's Whitehawk Therapeutics position peaked at $182K in Q3 2022.
  • 76 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2022.

Based on Trexquant Investment's 13F filing for Q4 2022, filed 13 Feb 2023.